| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 79 |
| 1 | AMBRISENTAN | 70 |
| 2 | FUROSEMIDE | 64 |
| 3 | SILDENAFIL CITRATE | 64 |
| 4 | ALBUTEROL SULFATE | 55 |
| 5 | SILDENAFIL | 47 |
| 6 | SILDENAFIL POWDER, | 42 |
| 7 | ACETAMINOPHEN | 40 |
| 8 | PREDNISONE | 36 |
| 9 | GALSULFASE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERTACONAZOLE NITRATE | 5 | 0.0309 |
| 1 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 2 | ADAPALENE AND BENZOYL PEROXIDE | 1 | 0.0185 |
| 3 | CIPAGLUCOSIDASE ALFA-ATGA | 1 | 0.0110 |
| 4 | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | 1 | 0.0109 |
| 5 | GALSULFASE | 35 | 0.0090 |
| 6 | MIGLUSTAT | 10 | 0.0085 |
| 7 | BIRCH TRITERPENES | 2 | 0.0072 |
| 8 | EDARAVONE | 11 | 0.0069 |
| 9 | LARONIDASE | 25 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 104 |
| 1 | Endothelin Receptor Antagonist [EPC] | 103 |
| 2 | Loop Diuretic [EPC] | 75 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 67 |
| 5 | Benzodiazepine [EPC] | 58 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 50 |
| 7 | Prostacycline Vasodilator [EPC] | 48 |
| 8 | Proton Pump Inhibitor [EPC] | 44 |
| 9 | Insulin Analog [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Enzyme Stabilizer [EPC] | 10 | 0.0085 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 50 | 0.0037 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 10 | 0.0035 |
| 4 | Plasma Kallikrein Inhibitor [EPC] | 6 | 0.0025 |
| 5 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 8 | 0.0023 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 5 | 0.0011 |
| 7 | Prostacycline [EPC] | 1 | 0.0011 |
| 8 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 9 | Benzothiazole [EPC] | 2 | 0.0009 |